申请人:Eisai R&D Management Co., Ltd.
公开号:EP2241567A1
公开(公告)日:2010-10-20
Compounds represented by formula (I) and pharmaceutically acceptable salts thereof have excellent sodium channel inhibitory action and are useful as therapeutic agents and analgesics for various kinds of neuralgia, neuropathy, epilepsy, insomnia, premature ejaculation and the like.
wherein Q represents ethylene, etc., R1, R2 and R3 represent hydrogen, etc., X1 represents C1-6 alkylene, etc., X2 represents C1-6 alkylene, etc., A1 represents a 5- to 6-membered heterocyclic group, etc., and A2 represents C6-14 aryl, etc.
式 (I) 所代表的化合物及其药学上可接受的盐类具有出色的钠通道抑制作用,可用作各种神经痛、神经病、癫痫、失眠、早泄等疾病的治疗剂和镇痛剂。
其中 Q 代表乙烯等,R1、R2 和 R3 代表氢等,X1 代表 C1-6 亚烷基等,X2 代表 C1-6 亚烷基等,A1 代表 5 至 6 元杂环基团等,A2 代表 C6-14 芳基等。